SEC 13F Intelligence

Acadian Asset Management LLC / EBS

Acadian Asset Management LLC’s Emergent Biosolutions Inc Position

Does Acadian Asset Management LLC own Emergent Biosolutions Inc (EBS)? Yes1.38M shares worth $11M (+0.02% of its 13F portfolio) as of Q1 2026, up from 1.11M shares the prior filed quarter.

Position Value
$11M
Q1 2026
Shares
1.38M
% of Portfolio
+0.02%
Quarters Held
27
currently held

Position History EBS

Reported value by quarter
Q4 ’18: $55MQ4 ’18Q1 ’19: $36MQ2 ’19: $25MQ4 ’19: $16MQ2 ’20: $9MQ2 ’20Q3 ’20: $12MQ4 ’20: $13MQ1 ’21: $10MQ2 ’21: $11MQ2 ’21Q3 ’21: $7MQ4 ’21: $5MQ1 ’22: $2MQ2 ’22: $1MQ2 ’22Q3 ’22: $1MQ4 ’22: $2MQ1 ’23: $27,000Q3 ’23: $249,000Q3 ’23Q4 ’23: $535,000Q1 ’24: $74,000Q2 ’24: $739,000Q3 ’24: $853,000Q3 ’24Q4 ’24: $2MQ1 ’25: $4MQ2 ’25: $6MQ3 ’25: $10MQ3 ’25Q4 ’25: $14MQ1 ’26: $11Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.38M$11M+0.02%
Q4 20251.11M$14M+0.02%
Q3 20251.18M$10M+0.02%
Q2 2025974.6K$6M+0.01%
Q1 2025833.3K$4M+0.01%
Q4 2024201.5K$2M+0.01%
Q3 2024102.3K$853,0000.00%
Q2 2024108.6K$739,0000.00%
Q1 202429.5K$74,0000.00%
Q4 2023223.4K$535,0000.00%
Q3 202373.4K$249,0000.00%
Q1 20232.6K$27,0000.00%
Q4 2022190.6K$2M+0.01%
Q3 202256.8K$1M+0.01%
Q2 202237.8K$1M+0.01%
Q1 202255.5K$2M+0.01%
Q4 2021105.5K$5M+0.02%
Q3 2021145.6K$7M+0.03%
Q2 2021171.4K$11M+0.04%
Q1 2021108.0K$10M+0.04%
Q4 2020144.0K$13M+0.05%
Q3 2020115.1K$12M+0.05%
Q2 2020113.3K$9M+0.04%
Q4 2019299.7K$16M+0.07%
Q2 2019520.3K$25M+0.12%
Q1 2019719.0K$36M+0.16%
Q4 2018932.7K$55M+0.27%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Acadian Asset Management LLC’s full portfolio or all institutional holders of EBS.